Aerovate Therapeutics shares are trading lower after TD Cowen downgraded the stock from Buy to Hold.
Portfolio Pulse from Benzinga Newsdesk
Aerovate Therapeutics shares are trading lower after TD Cowen downgraded the stock from Buy to Hold.
June 18, 2024 | 11:39 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aerovate Therapeutics shares are trading lower following a downgrade by TD Cowen from Buy to Hold.
The downgrade from TD Cowen is likely to negatively impact investor sentiment and lead to a short-term decline in Aerovate Therapeutics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100